House Committee Pens Letter to McKinsey & Co. Over Opioid Crisis Role

The House Committee on Oversight and Reform has requested that consulting firm McKinsey & Co. produce documents detailing its work for opioid makers, including Purdue Pharma.

In its letter to McKinsey, penned by committee chair Rep. Carolyn Maloney (D-N.Y.), the committee said it’s probing the company’s work “on behalf of industries causing public harm” and is examining the firm’s “apparent failure to monitor and prevent harmful practices” related to the opioid crisis.

The committee is also investigating an alleged conflict of interest. “Purdue Pharma’s records show that at the same time McKinsey was advising FDA, including offices responsible for opioid programs, the company was also advising Purdue on how to lobby FDA,” said the letter.

The committee asked that McKinsey produce all relevant documents and information by Nov. 19.